Viewing StudyNCT00090896



Ignite Creation Date: 2024-05-05 @ 11:37 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00090896
Status: COMPLETED
Last Update Posted: 2020-08-03
First Post: 2004-09-07

Brief Title: CP-675206 CTLA4-Blocking Monoclonal Antibody Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
Sponsor: Jonsson Comprehensive Cancer Center
Organization: Jonsson Comprehensive Cancer Center

Conditions & Keywords Data

Conditions:
Name
Melanoma Skin
Keywords:
Name View
recurrent melanoma View
stage III melanoma View
stage IV melanoma View